```html

Xanthoma Eruptum (Skin Eruptions)

What is Xanthoma eruptum (skin eruptions)?

Xanthoma eruptum, also called eruptive xanthoma, is a sudden appearance of small, yellow‑orange, dome‑shaped papules on the skin. The lesions are usually 1–5 mm in diameter, may have a reddish halo, and often cluster on the trunk, buttocks, shoulders, and extensor surfaces of the limbs. They develop when excess lipids (mainly triglycerides) deposit in the skin’s macrophages, turning them into “foam cells” that give the characteristic yellow color.

Although the lesions themselves are benign, eruptive xanthomas are a visual clue that the body’s lipid metabolism is out of balance. They can signal an underlying metabolic disturbance that, if left untreated, may increase the risk of pancreatitis, cardiovascular disease, and other serious conditions.

Common Causes

Several metabolic, genetic, and medication‑related conditions can trigger eruptive xanthomas. The most frequently reported causes include:

• Severe hypertriglyceridemia (fasting triglycerides > 1000 mg/dL). This is the classic trigger.
• Familial hyperlipoproteinemia types I, V, and III, which are inherited disorders of lipid metabolism.
• Uncontrolled diabetes mellitus, especially type 2 diabetes with poor glycemic control.
• Alcoholic liver disease – chronic heavy alcohol use raises triglyceride levels.
• Nephrotic syndrome – loss of proteins in the urine leads to compensatory lipid overproduction.
• Medications that raise triglycerides, such as:
  • Retinoids (isotretinoin, acitretin)
  • Corticosteroids
  • Protease inhibitors (used for HIV)
  • β‑adrenergic agonists
• Hypothyroidism – low thyroid hormone slows lipid clearance.
• Obesity and metabolic syndrome – central obesity, hypertension, and insulin resistance cluster together with high triglycerides.
• Rare systemic diseases such as:
  • Lipoprotein lipase deficiency
  • Acute pancreatitis (as a consequence of very high triglycerides)

In most cases, eruptive xanthomas appear within days to weeks after triglyceride levels surge.

Associated Symptoms

While the skin lesions are the primary manifestation, patients often experience other signs that point to the underlying metabolic problem:

• Fatigue or weakness (common in uncontrolled diabetes or hypothyroidism).
• Abdominal pain, nausea, or vomiting – warning signs of pancreatitis caused by severe hypertriglyceridemia.
• Weight gain, especially around the abdomen.
• Frequent urination and increased thirst (hyperglycemia).
• Swelling of the legs or ankles (edema) in nephrotic syndrome.
• Yellowing of the skin or eyes (jaundice) if liver disease is present.
• Other types of xanthomas (tuberous, tendon, or planar) that may appear on elbows, knees, or tendons.

When to See a Doctor

Because eruptive xanthomas are a marker of potentially dangerous lipid elevations, prompt evaluation is important. Seek medical attention if you notice:

• Sudden appearance of multiple yellow‑orange papules, especially if they are itchy or painful.
• Symptoms of pancreatitis – severe upper abdominal pain that radiates to the back, accompanied by vomiting or fever.
• Signs of uncontrolled diabetes (excessive thirst, frequent urination, unexplained weight loss).
• Rapid weight gain, swelling, or foamy urine suggestive of kidney disease.
• Any new skin eruption that spreads quickly or is accompanied by fever, chills, or malaise.

Even if you feel well, a dermatologist or primary‑care physician should evaluate new eruptive xanthomas because they often reveal hidden metabolic disease.

Diagnosis

Evaluation typically follows a stepwise approach:

1. Clinical Examination

• Visual inspection of the lesions – size, color, distribution.
• Palpation to assess firmness; lesions are usually soft to moderately firm.
• Documentation of any other skin findings (e.g., tendinous xanthomas).

2. Laboratory Tests

• Lipid panel – fasting triglycerides, total cholesterol, LDL‑C, HDL‑C.
• Blood glucose & HbA1c – to identify diabetes or pre‑diabetes.
• Thyroid‑stimulating hormone (TSH) and free T4 – screen for hypothyroidism.
• Renal function (creatinine, BUN) and urine protein – evaluate nephrotic syndrome.
• Liver function tests (ALT, AST, GGT, bilirubin) – look for alcoholic or non‑alcoholic fatty liver disease.

3. Imaging (if indicated)

• Abdominal ultrasound or CT scan when pancreatitis is suspected.
• Echocardiogram in patients with severe hyperlipidemia to assess early atherosclerotic changes.

4. Skin Biopsy (rarely needed)

If the diagnosis is unclear, a 3‑mm punch biopsy can confirm the presence of lipid‑laden macrophages (foam cells) in the dermis. Histology helps differentiate eruptive xanthoma from other papular eruptions such as molluscum contagiosum or syringomas.

Treatment Options

The cornerstone of therapy is correcting the underlying lipid abnormality. Treatment can be divided into medical interventions and supportive skin care.

Medical Management

• Dietary modification – limit simple sugars, refined carbs, and alcohol; adopt a Mediterranean‑style diet rich in omega‑3 fatty acids, nuts, whole grains, and fatty fish.
• Weight loss – a 5‑10 % reduction in body weight can lower triglycerides by 10‑20 %.
• Pharmacologic lipid‑lowering agents:
  • Fibrates (e.g., fenofibrate, gemfibrozil) – first‑line for severe triglyceride reduction.
  • Omega‑3 fatty acid ethyl esters (e.g., icosapent ethyl) – especially useful when triglycerides > 500 mg/dL.
  • Niacin – can lower TGs but is used less often because of side effects.
  • Statins – essential if LDL‑C is also elevated or if cardiovascular risk is high.
• Control of co‑existing disorders:
  • Intensify insulin therapy or add oral hypoglycemics for diabetes.
  • Start levothyroxine for hypothyroidism.
  • Use ACE inhibitors or ARBs in nephrotic syndrome to reduce proteinuria.
• Medication review – discontinue or replace drugs that raise triglycerides when possible (e.g., switch isotretinoin to a non‑retinoid acne treatment).

Skin‑Directed Care

• Gentle cleansing with mild soap; avoid harsh scrubs that may irritate lesions.
• Topical corticosteroids are generally not needed, but a low‑potency steroid can reduce itching if present.
• Moisturizers containing ceramides help maintain barrier function.
• Lesions typically regress within weeks to months once triglyceride levels fall below 500 mg/dL.

Follow‑up

Repeat lipid panel after 4–6 weeks of therapy. If triglycerides remain > 500 mg/dL, consider specialist referral (endocrinology or lipidology) for intensive treatment.

Prevention Tips

• Maintain a balanced diet low in added sugars and saturated fats.
• Limit alcohol intake – no more than 1 drink per day for women and 2 for men.
• Engage in regular physical activity (≥150 minutes moderate aerobic exercise per week).
• Achieve and sustain a healthy body weight; use a waist‑circumference goal of < 40 cm for men and < 35 cm for women.
• Screen fasting lipid profile at least once every 5 years, or annually if you have risk factors (family history, diabetes, obesity).
• Take prescribed lipid‑lowering medications exactly as directed; never stop abruptly without consulting your doctor.
• Monitor blood glucose and thyroid function if you have known diabetes or thyroid disease.
• Review all over‑the‑counter and prescription medications with your pharmacist to identify possible triglyceride‑increasing agents.

Emergency Warning Signs

Key Takeaways

Eruptive xanthoma is more than a cosmetic issue; it is a skin‑visible sign that the body’s triglyceride handling is severely impaired. Prompt evaluation, aggressive lipid‑lowering therapy, and lifestyle changes usually lead to rapid clearing of the lesions and reduce the risk of life‑threatening complications such as pancreatitis and cardiovascular disease.

References:

• Mayo Clinic. “Eruptive xanthomas.” Accessed June 2024. https://www.mayoclinic.org
• American Heart Association. “Triglycerides.” Updated 2023. https://www.heart.org
• National Institute of Diabetes and Digestive and Kidney Diseases. “Hypertriglyceridemia.” 2022. https://www.niddk.nih.gov
• Cleveland Clinic. “Eruptive Xanthomas: Causes, Symptoms, and Treatment.” 2023. https://my.clevelandclinic.org
• World Health Organization. “Non‑communicable diseases: Lipid disorders.” 2021. https://www.who.int

```